Erythrocytosis Summary Interpretation
Use
The test is useful for incorporating and summarizing subsequent results into an overall interpretation for the REVE2 / Erythrocytosis Evaluation, Blood. The etiology of congenital (inherited) erythrocytosis can be due to several abnormalities like high oxygen affinity hemoglobin variants, genetic variants in the erythropoietin receptor gene, and genetic variants in the oxygen-sensing pathway (PHD2/EGLN1, HIF2A/EPAS1, VHL) or BPGM variants causing 2,3-BPG deficiency. A summary interpretation that incorporates all testing performed is beneficial to the ordering clinician.
Special Instructions
Not provided.
Limitations
No significant cautionary statements were provided. However, the summary is provided after additional testing is complete to incorporate all subsequent results into an overall evaluation. Therefore, it's essential for proper test selection and specimen handling to ensure accurate results.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 59465-5 - Path Rev
- 59465-5 - Path Rev
- 18771-6 - Provider signing name
Result Turnaround Time
3-25 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Container
EDTA
Storage Instructions
Refrigerated